Skip to main content

Table 2 Changes in lipid profile after 24 weeks of therapy

From: Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

 

AP (n = 71)

PL (n = 70)

Baseline

24 weeks

Baseline

24 weeks

Tot-C (mg/dL)

224 ± 45

211 ± 44*

218 ± 38

221 ± 40

LDL-C (mg/dL)

133 ± 36

119 ± 33*

128 ± 29

130 ± 32

NHDL-C (mg/dL)

174 ± 42

158 ± 41*

168 ± 36

171 ± 39

HDL-C (mg/dL)

51 ± 11

53 ± 13*

50 ± 12

50 ± 10

TG (mg/dL)

151 ± 82

142 ± 93§

160 ± 87

164 ± 100

  1. * = p < 0.01 ARM vs Placebo. § = p < 0.05 24 weeks vs Baseline
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X